Industry wants US FDA to reshuffle its priorities on medtech guidelines
This article was originally published in SRA
Executive Summary
US medtech industry association AdvaMed believes that the Food and Drug Administration's annual list of medical device guidelines it plans to issue in this fiscal year misses out some important guidelines that are of high priority to industry because of the lack of transparency/predictability in the areas they would cover1.